Halozyme To Present At Upcoming Virtual Investor Conferences
SAN DIEGO, Sept. 9, 2020 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Dr. Helen Torley, president and chief executive officer, will be participating in the following investor conferences: Cantor Virtual Global Healthcare Conference at 10:40 a.m. ET /…
Comments Off on Halozyme To Present At Upcoming Virtual Investor Conferences